KET-MCI: A Pilot Safety and Tolerability Study of Single Infusion Intravenous Ketamine for Older Adults with Depression and Mild Cognitive Impairment

已完结 10 由 heihei 发布于 2026/10/18 17:58:59

DOI:10.1016/j.jagp.2026.02.005
作者：Rachel Fremont M.D., Ph.D. ,?Amelia Karim B.A. ,?Tanya Peguero Estevez M.D. ,?Catherine McDonough M.S. ,?Arianna LaBarbiera B.A. ,?Adriana Feder M.D. ,?Georges Naasan M.D. ,?Andrew Delgado M.D. ,?Denn
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：ObjectiveThis open-label clinical trial primarily examined the safety and tolerability of ketamine treatment in patients with mild cognitive impairment and Major Depressive Disorder (MCI-D).

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Long-Term Legume Cultivation Affects the Soil Bacterial Community via Altering the Soil Pore Structure in Coal Mine Reclamation Agroecosystems.